Longevity Drug Index / Rilmenidine
Rilmenidine
A blood pressure drug that mimicked calorie restriction and extended lifespan in worms.
How it works
Rilmenidine acts on imidazoline I1 receptors in the brainstem, lowering nerve signals that raise blood pressure. In worms, the same receptor pathway (called nischarin) appears to trigger changes similar to eating less, including more autophagy.
How it could help longevity
Calorie restriction is the most reliable way to extend lifespan in animals, but it is hard for people to sustain. Rilmenidine is one of a few existing drugs that seem to switch on similar biology, and it is already approved and generally well tolerated.
Animal studies
- Worms, 2023Rilmenidine extended lifespan and healthspan in the worm C. elegans, even when started later in life.
- Mice, 2023In mice it produced gene activity changes in the liver and kidney resembling calorie restriction. No mouse lifespan study has been reported yet.
Human studies
- AgingThere are no human aging data. Its human experience comes from decades of use for high blood pressure.
Safety and side effects
Drowsiness, dry mouth and dizziness are the most common side effects, and it can lower blood pressure too much in people whose pressure is normal.
Our view
An interesting early lead, but worm results often fail to carry over to mammals. It needs a proper mouse lifespan study before it can be taken seriously.
Sources
- Bennett et al., Aging Cell 2023: rilmenidine extends lifespan and healthspan in C. elegans
- ClinicalTrials.gov: registered studies of Rilmenidine
Links open PubMed or ClinicalTrials.gov searches for each study.
Last reviewed 11 November 2026. General information, not medical advice. None of these drugs is approved to slow aging.